Contributors
Sharon G. Adler(UCLA Medical Center), Andrew A. House(Western University), Ursula C. Brewster, Arthur Greenberg, Paula Dennen, Lakshman Gunaratnam(Western University), C. Barrett Bowling, Andrew S. Bomback(Columbia University), Manuela Födinger(Sigmund Freud Privatuniversität Wien), Todd Fairhead, Jeffrey S. Berns(University of Pennsylvania), Michael Emmett(Baylor University Medical Center), Horacio J. Adrogué(Methodist Hospital), Josephine P. Briggs(University of Michigan), Jacques R. Daoud, Thomas D. DuBose(Toyota Motor Corporation (Switzerland)), Dick de Zeeuw(University Medical Center Groningen), D. Jordi Goldstein-Fuchs, Gary C. Curhan(Brigham and Women's Hospital), Debbie S. Gipson(University of Michigan), Jonathan Barratt(University of Leicester), Susan L. Furth(Children's Hospital of Philadelphia), Sindhu Chandran(Cedars-Sinai Medical Center), John Feehally(University of Leicester), Michael Allon(University of Alabama at Birmingham), Carmen Ávila-Casado(Instituto Nacional de Cardiología), Paola Fioretto(University of Padua), Lawrence Copelovitch(Children's Hospital of Philadelphia), Vicente Arroyo(European Foundation for the Study of Chronic Liver Failure), Steven G. Coca(Icahn School of Medicine at Mount Sinai), Fernando C. Fervenza(Mayo Clinic), Vimal K. Derebail(University of North Carolina at Chapel Hill), Peter J. Conlon(Botsford Hospital), Hina Arif‐Tiwari(Banner - University Medical Center Tucson), Friedhelm Hildebrandt(Boston Children's Hospital), Susan Hou(Salem VA Medical Center), Ronald J. Falk(University of North Carolina at Chapel Hill), Joseph V. Bonventre(Brigham and Women's Hospital), Javier Fernández, Martin C. Gregory(University of Utah), Scott J. Gilbert, Vivette D. D’Agati(Columbia University), Jonathan Hogan(University of Pennsylvania), Daniel C. Cattran(Toronto Rehabilitation Institute), Raymond Hakim, Arlene B. Chapman(Emory University), Jagbir Gill(University of British Columbia), Michelle Hladunewich(Sunnybrook Health Science Centre), Todd W.B. Gehr, Robin K. Avery(Johns Hopkins University)
Cited by 0
Related Papers
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
|Data Archiving and Networked Services (DANS)|2002|11.7k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
|Autophagy|2016|6k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k